These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 151116)

  • 21. B lymphocyte activation by insoluble anti-immunoglobulin: induction of immunoglobulin secretion by a T cell-dependent soluble factor.
    Parker DC; Fothergill JJ; Wadsworth DC
    J Immunol; 1979 Aug; 123(2):931-41. PubMed ID: 379222
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible role of neuraminidase in activated T cells in the recognition of allogeneic Ia.
    Taira S; Nariuchi H
    J Immunol; 1988 Jul; 141(2):440-6. PubMed ID: 2968401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice.
    Engers HD; Louis JA; Zubler RH; Hirt B
    J Immunol; 1981 Dec; 127(6):2280-5. PubMed ID: 6457871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferation of F1 hybrid B cells stimulated in vitro by a factor released during abortive histoincompatibility recognition reaction by irradiated parental cells.
    Kennedy JC; Ekpaha-Mensah JA
    Transplant Proc; 1973 Dec; 5(4):1407-10. PubMed ID: 4272809
    [No Abstract]   [Full Text] [Related]  

  • 25. [Further qualitative and quantitative studies on the inhibition of in vivo T-cell reactions by drugs].
    Schmassmann E; Alföldy P; Lemmel EM
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1132-5. PubMed ID: 77098
    [No Abstract]   [Full Text] [Related]  

  • 26. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to alloantigens in vitro, amplification of the development of cytotoxic T lymphocytes by lipopolysaccharide and polyadenylic:polyuridylic acid.
    Narayanan PR; Kloehn DB; Sundharadas G
    J Immunol; 1978 Dec; 121(6):2502-8. PubMed ID: 152794
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulatory T cells in pregnancy. IV. Genetic characteristics and mode of action of early MLR suppressive T cell subpopulations.
    Chaouat G; Voisin GA
    J Immunol; 1981 Oct; 127(4):1335-9. PubMed ID: 6456305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosensitivity of sensitized and nonsensitized human lymphocytes evaluated in vitro.
    Nichols WS; Troup GM; Anderson RE
    Am J Pathol; 1975 Jun; 79(3):499-508. PubMed ID: 124534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.
    Krieger J; Jenis DM; Chesnut RW; Grey HM
    J Immunol; 1988 Jan; 140(2):388-94. PubMed ID: 2961812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens].
    Nesterenko VG; Gruner ShG
    Biull Eksp Biol Med; 1980 Jun; 89(6):708-10. PubMed ID: 6967339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of mouse anti-SRBC antibody responses by placental extracts. II. Antigen specificity and regulatory role of B and T cell populations affected by two distinct placental fractions.
    Bobé P; Kanellopoulos-Langevin C; Bleux C; Voisin GA
    J Immunol; 1986 Jan; 136(2):574-81. PubMed ID: 2416814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087
    [No Abstract]   [Full Text] [Related]  

  • 34. The mouse-primed lymphocyte typing test. III. Dissociation of T lymphocyte-stimulating determinants and antibody-defined specificities of the I region-associated Ia antigens.
    Peck AB; Klein J; Wigzell H
    J Immunol; 1980 Sep; 125(3):1978-86. PubMed ID: 6157729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.
    Coeshott CM; Chesnut RW; Kubo RT; Grammer SF; Jenis DM; Grey HM
    J Immunol; 1986 Apr; 136(8):2832-8. PubMed ID: 2420871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mouse mutant "motheaten." II. Functional studies of the immune system.
    Sidman CL; Shultz LD; Unanue ER
    J Immunol; 1978 Dec; 121(6):2399-404. PubMed ID: 363947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse.
    Weinstein Y; Ran S; Segal S
    J Immunol; 1984 Feb; 132(2):656-61. PubMed ID: 6228595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orchestration of partner cell preferences of cooperating T and B lymphocytes derived from primed conventional F1 mice.
    Katz DH; Katz LR; Bogowitz CA
    J Immunol; 1980 Sep; 125(3):1109-16. PubMed ID: 6967889
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures.
    Sjöberg O; Andersson J; Möller G
    J Immunol; 1972 Dec; 109(6):1379-85. PubMed ID: 4263894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.